Source comparison
Selank Amidate vs Semax Amidate: Research Application Comparison
Primary mechanism GABAergic modulation via enkephalin upregulation BDNF expression and monoamine synthesis enhancement Selank for stress-response models; Semax for learning/memory protocols Onset (intranasal) 15–30 minutes Functionally equivalent for acute stu
This comparison does not assign a generated winner or score.
- Primary mechanism
- GABAergic modulation via enkephalin upregulation
- BDNF expression and monoamine synthesis enhancement
- Selank for stress-response models; Semax for learning/memory protocols
- Onset (intranasal)
- 15–30 minutes
- Functionally equivalent for acute studies
- Half-life (amidate form)
- ~2 hours
- ~90 minutes
- Minimal practical difference. Both require daily dosing in chronic models
- CNS penetration route
- Olfactory epithelium (intranasal); systemic (SC)
- Intranasal preferred for CNS-targeted research
- Preclinical anxiety reduction
- 28–34% reduction in cortisol and IL-6 (rat models)
- Minimal direct anxiolytic effect
- Selank is the validated compound for anxiety research
- Cognitive enhancement evidence
- Minimal direct effect
- 40–60% increase in hippocampal BDNF; improved Morris water maze performance
- Semax is the validated compound for memory/learning studies
- Receptor downregulation risk
- None observed in repeated-dose studies
- None observed
- Both compounds avoid tolerance mechanisms seen with GABAergic drugs
- Storage (lyophilised)
- −20°C, desiccated
- No difference. Standard peptide storage protocol
- Reconstituted stability
- 28 days at 2–8°C
- Both degrade rapidly if temperature-controlled storage is compromised
- Regulatory status
- Research use only. Not FDA-approved
- Neither compound is a legal therapeutic outside research contexts
- The table underscores a critical constraint: research application determines superiority. Selank is the better choice for studies involving stress response, HPA axis modulation, or anxiolytic mechanism investigation. Semax is superior for neuroplasticity research, cognitive enhancement protocols, or BDNF pathway studies. Using Selank in a memory consolidation study or Semax in an anxiety model is a methodological error. The mechanisms do not overlap enough to substitute one for the other.